Susvimo Prices, Coupons, Copay Cards & Patient Assistance
Susvimo (ranibizumab ophthalmic) is a member of the anti-angiogenic ophthalmic agents drug class and is commonly used for Diabetic Macular Edema, Diabetic Retinopathy, and Macular Degeneration.
Susvimo prices
Intravitreal Solution
100 mg/mL Susvimo intravitreal solution from $8,550.16 for 0.1 milliliters
| Quantity | Per unit | Price |
|---|---|---|
| 0.1 milliliters | $85,501.60 | $8,550.16 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Susvimo Coupons, Copay Cards and Rebates
Susvimo offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Susvimo Genentech Ophthalmology Co-pay Program
Eligible commercially insured patients may pay $0 on out-of-pocket costs per treatment; program covers up to $15,000 per calendar year.
- Applies to:
- Susvimo
- Number of uses:
- Per prescription per calendar year
Form more information phone: 855-218-5307 or Visit website
Susvimo Genentech Ophthalmology Co-pay Program-Check Request
Eligible commercially insured patients may request a reimbursement for a claim you already paid.
- Applies to:
- Susvimo
- Number of uses:
- One rebate per prescription fill
Form more information phone: 855-218-5307 or Visit website
Patient Assistance & Copay Programs for Susvimo
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 866-316-7263 Visit website
Provider: Genentech Patient Foundation
Eligibility requirements:- Uninsured or Underinsured with no prescription coverage for needed medication
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- The Genentech Access to Care Foundation is now the Genentech Patient Foundation. Eligibility determined on a case-by-case basis. Call for most recent medications as the list is subject to change. This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 888-941-3331 or 866-422-2377 Visit website
Provider: Genentech Opthamology Access Solutions
Eligibility requirements:- Determined case by case
- Based on FPL
- Medically appropriate condition/diagnosis
- Must be treated by US licensed healthcare provider
- Eligibility determined on a case-by-case basis. Contact program for details.
- Susvimo (ranobizumab) Implant; Ocular
More information please phone: 833-393-4363 or 866-422-2377 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Vabysmo
Vabysmo eye injection is used to treat eye diseases neovascular (wet) age-related macular ...
Eylea
Eylea is used to treat neovascular (wet) age-related macular degeneration (AMD), macular edema ...
Izervay
Izervay (avacincaptad pegol) is used for treating geographic atrophy (GA) due to age-related ...
Syfovre
Syfovre (pegcetacoplan) treatment for geographic atrophy (GA) a form of dry age-related macular ...
Eylea HD
Eylea HD is used to treat neovascular (wet) age-related macular degeneration (AMD), diabetic ...
Lucentis
Lucentis is used to treat the wet form of age-related macular degeneration. Learn about side ...
Pavblu
Pavblu (aflibercept-ayyh) is a biosimilar to Eylea that may be used to treat the following eye ...
Yesafili
Yesafili (aflibercept-jbvf) is an interchangeable biosimilar to Eylea that may be given by ...
More about Susvimo (ranibizumab ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español